Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

Axem Neurotechnology Inc.

$200,000.00

Commercialization preparation

FY 2023-24 · 2023-06-01

Summary
Axem Neurotechnology is preparing to go to market with a digital health service facilitating at-home stroke recovery. The current project will enable Axem to enhance its in-house manufacturing capacities, refine its device to enable a more scalable business model, and also improve its ability to use data from its medical device to personalize post-stroke recovery.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Dartmouth|Dartmouth, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
761868496
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2024-03-20
Agreement Number
1006930
Agreement Start Date
2023-06-01
Agreement Title
Commercialization preparation
Agreement Title (French)
Préparation à la commercialisation
Agreement Type
Contribution
Agreement Value
$200,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Axem Neurotechnology is preparing to go to market with a digital health service facilitating at-home stroke recovery. The current project will enable Axem to enhance its in-house manufacturing capacities, refine its device to enable a more scalable business model, and also improve its ability to use data from its medical device to personalize post-stroke recovery.
Description (French)
Axem Neurotechnology se prépare à commercialiser un service de santé numérique facilitant la récupération à domicile après un accident vasculaire cérébral. Le projet actuel permettra à Axem de renforcer ses capacités de fabrication internes, d’affiner son dispositif pour permettre un modèle commercial plus évolutif, et également d’améliorer sa capacité à utiliser les données de son dispositif médical pour personnaliser la récupération post-AVC.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Dartmouth--Cole Harbour
Federal Riding (French)
Dartmouth--Cole Harbour
Federal Riding Number
12004
NAICS Code
541514
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
761868496
Recipient City
Dartmouth|Dartmouth
Recipient Country
CA
Recipient Legal Name
Axem Neurotechnology Inc.
Recipient Postal Code
B3B 1V7
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2023-2024-Q1-1006930